CD8A and Miyoshi myopathy: In vitro assays unveiled that compromised BM CD8 + T function and diminished mitochondrial mass in MM patients correlated with heightened long-chain FAs uptake, primarily driven by elevated FATP1 expression, with FATP1 inhibition ameliorating CD8 + T cell dysfunction [27].